Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» odronextamab
odronextamab
FDA blocks approval of Regeneron's blood cancer drug over confirmatory trial enrollment
Fierce Biotech
Mon, 03/25/24 - 11:27 am
Regeneron
FDA
odronextamab
clinical trials
blood cancers
Regeneron resumes enrollment in lymphoma drug trials
Reuters
Mon, 05/17/21 - 11:05 pm
Regeneron
clinical trials
FDA
lymphoma
odronextamab
JPM: Regeneron has spoken with the FDA about odronextamab hold, hopes to get patients back soon
Fierce Biotech
Mon, 01/11/21 - 10:29 am
Regeneron
FDA
odronextamab
clinical hold
B-cell non-Hodgkin lymphoma
Regeneron's blood cancer hopeful odronextamab hit with FDA partial hold across several trials
Fierce Biotech
Tue, 12/15/20 - 10:49 am
Regeneron
FDA
clinical trials
odronextamab
B-cell non-Hodgkin lymphoma